Artelo Biosciences, Inc.
ARTL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001621221
No open-market purchases or sales by Artelo Biosciences, Inc. insiders were filed in the last 90 days; 10 institutions reported holding it in 13F filings for Q2 2026, worth $132.0K in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Artelo Biosciences, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 22 | 18 | −4 |
| Shares | 1.90M | 1.47M | −432.4K (−22.8%) |
| Value | $984.0K | $659.0K | −$325.0K (−33.0%) |
New holders (4)
Institutions that held Artelo Biosciences, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Snowden Capital Advisors LLC | 110,000 | $49.0K | 0.00% |
| HRT Financial LP | 27,952 | $12.0K | 0.00% |
| UBS Group AG | 18,283 | $8.00K | 0.00% |
| Keystone Wealth Partners | 15,000 | $7.00K | 0.00% |
Sold out (8)
Institutions that held Artelo Biosciences, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Kepos Capital LP | 200,000 | $104.0K |
| Citadel Advisors LLC | 78,586 | $41.0K |
| Commonwealth Equity Services, LLC | 27,470 | $14.0K |
| Two Sigma Advisers, LP | 16,000 | $8.00K |
| Millennium Management LLC | 11,977 | $6.00K |
| Bank of America Corp | 46 | $0 |
| FMR LLC | 65 | $0 |
| Global Wealth Management Investment Advisory, Inc. | 475 | $0 |